Compared with the HF group, the TAK-242-treated group presented increased LVEF and LVFS (Fig. 4A, B) and decreased LVESD, LVEDD, and BNP levels (Fig. 4C, D, E), indicating improved cardiac function. The gene discussed is NPPB; the disease is hydrops fetalis.